Olivier Trédan Selected Research

Olivier Trédan Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 08/2005
35	Breast Neoplasms (Breast Cancer) 11/2023 - 04/2010
5	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2011
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2011 - 08/2005
4	Disease Progression 01/2022 - 08/2005
3	Fatigue 10/2023 - 08/2018
3	Triple Negative Breast Neoplasms 10/2023 - 02/2015
3	Neutropenia 10/2022 - 10/2010
2	Diarrhea 10/2022 - 11/2017
2	Sarcoma (Soft Tissue Sarcoma) 07/2021 - 10/2010
2	Nausea 01/2018 - 08/2014
2	Vomiting 01/2018 - 08/2014
2	Weight Loss (Weight Reduction) 06/2010 - 08/2005
2	Hypoxia (Hypoxemia) 02/2009 - 05/2008
1	Septic Shock (Toxic Shock Syndrome) 10/2023
1	Colitis 10/2023
1	Residual Neoplasm 10/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 12/2021
1	Genomic Instability 12/2021
1	Circulating Neoplastic Cells 09/2021
1	Sarcopenia 08/2021

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2011
6	Hormones (Hormone)IBA 10/2023 - 11/2017
6	Estrogens (Estrogen)FDA Link 01/2023 - 10/2012
4	Trastuzumab (Herceptin)FDA Link 01/2023 - 12/2012
4	Gemcitabine FDA Link 10/2022 - 09/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 12/2005
3	ErbB Receptors (EGF Receptor)IBA 10/2023 - 12/2012
3	Tamoxifen FDA LinkGeneric 01/2023 - 06/2019
3	Vinorelbine (Navelbine)FDA LinkGeneric 10/2022 - 08/2005
3	AntigensIBA 10/2022 - 03/2014
3	MTOR InhibitorsIBA 12/2021 - 10/2015
3	EnzymesIBA 01/2021 - 10/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2015
3	Estrogen ReceptorsIBA 01/2021 - 10/2017
3	Everolimus FDA Link 10/2017 - 12/2013
2	RNA (Ribonucleic Acid)IBA 04/2024 - 11/2023
2	AnthracyclinesIBA 11/2023 - 07/2021
2	sacituzumab govitecanIBA 10/2023 - 10/2022
2	Estrogen Receptor alphaIBA 01/2023 - 04/2021
2	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2016
2	Capecitabine (Xeloda)FDA Link 10/2022 - 10/2021
2	eribulin FDA Link 10/2022 - 10/2021
2	Cyclin-Dependent Kinase 4IBA 10/2022 - 11/2017
2	PlatinumIBA 09/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 12/2021 - 09/2005
2	AntioxidantsIBA 08/2021 - 01/2021
2	Fulvestrant (Faslodex)FDA Link 01/2021 - 11/2017
2	Angiogenesis InhibitorsIBA 01/2021 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2011
2	Aromatase InhibitorsIBA 11/2017 - 10/2017
2	TOR Serine-Threonine KinasesIBA 10/2017 - 10/2017
2	Bevacizumab (Avastin)FDA Link 10/2015 - 06/2015
2	Oxygen (Dioxygen)IBA 06/2015 - 05/2008
2	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2013 - 02/2009
2	ParaffinIBA 11/2012 - 05/2011
2	TubulinIBA 12/2005 - 08/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023
1	taxaneIBA 10/2023
1	GlucocorticoidsIBA 10/2023
1	Sorafenib (BAY 43-9006)FDA Link 06/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	CytokinesIBA 01/2023
1	pembrolizumabIBA 01/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2022
1	Surface Antigens (Surface Antigen)IBA 10/2022
1	Immunoglobulin IsotypesIBA 10/2022
1	regorafenibIBA 01/2022
1	Steroid Receptors (Steroid Receptor)IBA 12/2021
1	niraparibIBA 10/2021
1	tetrachloroisophthalonitrile (Bravo)IBA 10/2021
1	Circulating Tumor DNAIBA 09/2021
1	Carboplatin (JM8)FDA LinkGeneric 06/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 04/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2021
1	AlpelisibIBA 01/2021
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	CatalaseIBA 01/2021
1	Glutathione PeroxidaseIBA 01/2021
1	Glycerol (Glycerine)FDA LinkGeneric 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Histidine (L-Histidine)FDA Link 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	Superoxide DismutaseIBA 01/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021
1	Advanced Oxidation Protein Products (AOPP)IBA 01/2021

Therapy/Procedure

21	Therapeutics 10/2023 - 12/2005
18	Drug Therapy (Chemotherapy) 11/2023 - 08/2005
5	Adjuvant Chemotherapy 10/2021 - 04/2010
4	Fitness Trackers 08/2021 - 08/2018
2	Immunotherapy 10/2023 - 04/2020
2	Radiotherapy 01/2023 - 12/2021
2	Precision Medicine 01/2022 - 07/2021
2	Ligation 06/2019 - 11/2012
1	Neoadjuvant Therapy 11/2023